Medical Necessity: Unexplained Clinical Variation in Care

I am a physician who writes and edits guidelines designed to assist in determining appropriate utilization of clinical resources. In a nutshell, the issue that pertains to today’s topic, medical necessity, is “unexplained clinical variation in care.”

What I mean by that is the fact that patients with similar clinical features and issues are treated very differently depending on variables unrelated to severity of illness, risk of deterioration, or clinical need.

What varies is the amount or intensity of care (testing, inpatient hospital care, procedures, etc.). This variation is called “unexplained,” as it persists even after taking into account items such as patient age, socioeconomic status, and illness details.

Importantly, a consistent finding is that this variation in the intensity of care is not associated with improved patient outcomes. That is, despite general belief to the contrary, more care is not necessarily better care.

This sort of variation has been identified across all manner of clinical entities, treatments, and variables. Care provided varies rather profoundly, for example, by geographic region in the U.S.. In general, more care, and a higher intensity of care, is rendered in the Northeast than in the West, for example.

Furthermore, this variation can be found within geographic regions, according to physician specialty and practice location, and variation exists even within individual groups of physicians. For example, unexplained variation exists between hospitals in the same or similar settings, and between individual clinicians within a single hospital or practice. This variation is not random, in that the same geographic areas, specialties, and individual doctors are found to provide more resource-intensive care than their counterparts.

What sort of variation do I mean, and how does this relate to medical necessity?

Important aspects of care to measure include those decisions and interventions that carry high cost and potential for risk of harm. An early measure was inpatient length of stay. A more recent measure has been the inpatient admission rate. For example, patients seen in the emergency department for the same reason and with similar clinical features are admitted to the hospital for inpatient care at rates that can vary significantly.

The cost ramifications of the admission decision are straightforward. Less appreciated is the consistent finding that being a patient in a hospital is quite risky, and therefore should only be considered when the benefit (that is to say, need) clearly outweighs the risk of harm. Study after study has found that somewhere in the neighborhood of 4 percent of hospitalized patients experience a preventable harm (for example wrong medication, wrong dose, hospital-acquired infection, etc.).

With this background, the importance of medical necessity becomes clear. Simply leaving it up to individual clinicians has resulted in the variation seen. At the same time, it is in no way a simple matter to standardize which patients need which type or amount of care.

For unexplained clinical variation, an implemented response is the expectation that clinical decisions and interventions (or at the least, payment for these interventions) be justifiable, that is, defendable according to some mutually accepted standard (in other words, documentation of medical necessity).

Various clinical tools, such as the MCG evidence-based guidelines, have been used by involved parties (for example, payors and auditors) to assist in the determination of when the clinical documentation supports a defined threshold of “medical necessity.”

It is crucial that whatever standards are applied, they be clinically “right,” that is, neither overly strict nor lenient, and seen as unbiased by all parties involved. An important means by which to achieve this standard and level of acceptance is to be strictly evidence-based. This entails the difficult process of searching for the best evidence, expertly interpreting the evidence, and incorporating new evidence when appropriate.

Correct usage of guidelines is likewise important. For example, the MCG guidelines are intended to supplement and support clinician-based decision-making, not replace it. They are designed to be used as guidance, not interpreted as inflexible rules. Our guidelines are very specific and detailed when the medical literature allows, and at the same time acknowledging of the “gray areas” of decision-making when the evidence is not as clear.

In either case, the guideline content is used to not only set a standard for how to determine severity of illness or need for a procedure, but also to provide a common set of key moving parts within any given clinical situation that should be documented and described.

It is through this consistent, appropriate use of evidence-based guidelines that the central, chronic issue of unexplained clinical variation can be recognized and addressed. Identification, determination, and documentation of medical necessity are the active ingredients in any attempt to reduce unexplained clinical variation in care.

Facebook
Twitter
LinkedIn

Bill Rifkin MD, FHM, FACP

Dr. Bill Rifkin is the associate vice president and managing editor of MCG Health. Dr. Rifkin oversees all research and content published by MCG Health that is focused on acute inpatient care. His expertise expands to hospital medicine and clinical care, where he has published multiple research documents.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Proactive Denial Management: Data-Driven Strategies to Prevent Revenue Loss

Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.

November 19, 2025
Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis: Bridging the Clinical Documentation and Coding Gap to Reduce Denials

Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.

September 24, 2025
2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025

Trending News

Featured Webcasts

Surviving Federal Audits for Inpatient Rehab Facility Services

Surviving Federal Audits for Inpatient Rehab Facility Services

Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.

November 13, 2025
E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

E/M Services Under Intensive Federal Scrutiny: Navigating Split/Shared, Incident-to & Critical Care Compliance in 2025-2026

During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.

August 26, 2025
The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24